Cargando…

Epstein Barr virus. Volume 2, One herpes virus: many diseases /

Epstein Barr virus (EBV) was discovered as the first human tumor virus around 50 years ago. Since its discovery in Burkitt's lymphoma it has been associated with various other malignancies, infectious mononucleosis and even autoimmune diseases. The two book volumes on EBV summarize the first 50...

Descripción completa

Detalles Bibliográficos
Clasificación:Libro Electrónico
Otros Autores: Münz, Christian (Editor )
Formato: Electrónico eBook
Idioma:Inglés
Publicado: Cham : Springer, 2015.
Colección:Current topics in microbiology and immunology ; 391.
Temas:
Acceso en línea:Texto completo

MARC

LEADER 00000cam a2200000 i 4500
001 EBOOKCENTRAL_ocn922887201
003 OCoLC
005 20240329122006.0
006 m o d
007 cr cnu|||unuuu
008 151005s2015 sz ob 001 0 eng d
040 |a N$T  |b eng  |e rda  |e pn  |c N$T  |d N$T  |d IDEBK  |d OCLCF  |d YDXCP  |d EBLCP  |d CDX  |d AZU  |d COO  |d GW5XE  |d OCLCQ  |d VT2  |d Z5A  |d OCLCQ  |d ESU  |d IOG  |d UAB  |d U3W  |d REB  |d OCLCQ  |d CEF  |d OCLCQ  |d UKMGB  |d WYU  |d OCLCO  |d OCLCA  |d UX0  |d UKAHL  |d OCLCQ  |d DCT  |d ERF  |d OCLCQ  |d AJS  |d OCLCQ  |d OCLCO  |d SNK  |d OCLCO  |d QGK  |d OCLCQ  |d OCLCO  |d OCLCQ 
015 |a GBB8J5072  |2 bnb 
016 7 |a 019093513  |2 Uk 
019 |a 985040290  |a 1005824425  |a 1011991134  |a 1022047766  |a 1026454771  |a 1048168483  |a 1071410017  |a 1111061608  |a 1112587724  |a 1119461641  |a 1162747125  |a 1204010812  |a 1259199642 
020 |a 9783319228341  |q (electronic bk.) 
020 |a 331922834X  |q (electronic bk.) 
020 |z 9783319228334 
020 |z 3319228331  |q (print) 
020 |z 9783319228334  |q (print) 
024 7 |a 10.1007/978-3-319-22834-1  |2 doi 
029 1 |a AU@  |b 000058376734 
029 1 |a AU@  |b 000058391281 
029 1 |a AU@  |b 000060385576 
029 1 |a AU@  |b 000061961498 
029 1 |a AU@  |b 000065090402 
029 1 |a NZ1  |b 16246376 
029 1 |a UKMGB  |b 019093513 
029 1 |a AU@  |b 000069348349 
035 |a (OCoLC)922887201  |z (OCoLC)985040290  |z (OCoLC)1005824425  |z (OCoLC)1011991134  |z (OCoLC)1022047766  |z (OCoLC)1026454771  |z (OCoLC)1048168483  |z (OCoLC)1071410017  |z (OCoLC)1111061608  |z (OCoLC)1112587724  |z (OCoLC)1119461641  |z (OCoLC)1162747125  |z (OCoLC)1204010812  |z (OCoLC)1259199642 
037 |a com.springer.onix.9783319228341  |b Springer Nature 
050 4 |a QR400.2.E68 
060 4 |a WC 571 
072 7 |a HEA  |x 039000  |2 bisacsh 
072 7 |a MED  |x 014000  |2 bisacsh 
072 7 |a MED  |x 022000  |2 bisacsh 
072 7 |a MED  |x 112000  |2 bisacsh 
072 7 |a MED  |x 045000  |2 bisacsh 
072 7 |a MJCL  |2 bicssc 
082 0 4 |a 616.99/4019  |2 23 
049 |a UAMI 
245 0 0 |a Epstein Barr virus.  |n Volume 2,  |p One herpes virus: many diseases /  |c Christian Münz, editor. 
246 3 0 |a One herpes virus: many diseases 
264 1 |a Cham :  |b Springer,  |c 2015. 
300 |a 1 online resource 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
347 |a text file 
347 |b PDF 
490 1 |a Current topics in microbiology and immunology ;  |v volume 391 
504 |a Includes bibliographical references and index. 
588 0 |a Vendor-supplied metadata. 
505 0 |a Preface -- EBV latency -- Chap. 1. EBNA1 -- Lori Frappier, University of Toronto, Canada -- Chap. 2. EBNA2 and its coactivator EBNA-LP -- Bettina Kempkes, Helmholtz Center Munich, Germany, and Paul D. Ling, Baylor College of Medicine, Houston, USA -- Chap. 3. The EBNA3 family: two oncoproteins and a tumour suppressor that are central to the biology of EBV in B cells- Martin J. Allday, Quentin Bazot and Robert E. White, Imperial College London, UK. Chap. 4. The latent membrane protein 1 (LMP1) -- Arnd Kieser and Kai R. Sterz, Helmholtz Center Munich, Germany. Chap. 5. Latent membrane protein 2 (LMP2) -- Osman Cen and Richard Longnecker, Northwestern University, Chicago, USA. Chap. 6. EBV non-coding RNAs -- Rebecca L. Skalsky and Bryan R. Cullen, Duke University, Durham, USA -- E. Lytic EBV infection -- 7. Viral entry -- Liudmila S. Chesnokova, Ru Jiang1 and Lindsey M. Hutt-Fletcher, Louisiana State University, Shreveport, USA -- Chap. 8. Epstein Barr virus lytic cycle reactivation -- Jessica McKenzie and Ayman El-Guindy, Yale University, New Haven, USA -- Immune responses to EBV -- Chap. 9. Innate immune recognition of EBV -- Anna Lünemann and David Nadal, University of Zürich, Switzerland and Martin Rowe, University of Birmingham, UK -- Chap. 10. Epstein-Barr virus specific humoral immune responses in health and disease -- Jaap M. Middeldorp, VU Medical Center, Amsterdam, The Netherlands -- Chap. 11. T cell responses to EBV -- Andrew D. Hislop and Graham S. Taylor, University of Birmingham, UK -- Chap. 12. Immune evasion by Epstein Barr virus -- Maaike E. Ressing, Michiel van Gent, Anna M. Gram, Marjolein Hooykaas, Sytse Piersma and Emmanuel Wiertz, Utrecht Medical Center, The Netherlands -- Animal models of EBV infection -- Chap. 13. Non-human primate lymphocryptoviruses: past, present, and future- Janine Mühe and Fred Wang, Harvard University, Boston, USA. Chap. 14. EBV infection of mice with reconstituted human immune system components -- Christian Münz, University of Zürich, Switzerland -- Therapy of EBV associated diseases -- Chap. 15. Adoptive T cell immunotherapy -- Stephen Gottschalk and Cliona Rooney, Baylor College of Medicine, Houston, USA -- Chap. 16. The Development of Prophylactic and Therapeutic EBV Vaccines -- Corey Smith and Rajiv Khanna, Queensland Institute of Medical Research, Brisbane, Australia -- Chap. 17. The biology and clinical utility of EBV monitoring in blood- Jennifer Kanakry and Richard Ambinder, Johns Hopkins University, Baltimore, USA -- Index. 
520 |a Epstein Barr virus (EBV) was discovered as the first human tumor virus around 50 years ago. Since its discovery in Burkitt's lymphoma it has been associated with various other malignancies, infectious mononucleosis and even autoimmune diseases. The two book volumes on EBV summarize the first 50 years of research on this tumor virus, starting with historical perspectives on discovery, oncogenicity and immune control, reviewing the role that the virus plays in the various associated diseases and concluding with a discussion on how the immune system keeps persistent EBV infection under control in healthy EBV carriers and can be used to treat EBV associated diseases. The respective 32 chapters are written by international experts from three continents for health care providers, biomedical researchers and patients that are affected by EBV. The assembled knowledge should help to understand EBV associated diseases better and to develop EBV specific vaccination in the near future. 
546 |a English. 
590 |a ProQuest Ebook Central  |b Ebook Central Academic Complete 
650 0 |a Epstein-Barr virus. 
650 0 |a Epstein-Barr virus diseases. 
650 2 |a Epstein-Barr Virus Infections 
650 2 |a Herpesvirus 4, Human 
650 6 |a Virus Epstein-Barr. 
650 6 |a Maladies associées au virus Epstein-Barr. 
650 7 |a Immunology.  |2 bicssc 
650 7 |a Medical microbiology & virology.  |2 bicssc 
650 7 |a Infectious & contagious diseases.  |2 bicssc 
650 7 |a Animal pathology & diseases.  |2 bicssc 
650 7 |a Oncology.  |2 bicssc 
650 7 |a HEALTH & FITNESS  |x Diseases  |x General.  |2 bisacsh 
650 7 |a MEDICAL  |x Clinical Medicine.  |2 bisacsh 
650 7 |a MEDICAL  |x Diseases.  |2 bisacsh 
650 7 |a MEDICAL  |x Evidence-Based Medicine.  |2 bisacsh 
650 7 |a MEDICAL  |x Internal Medicine.  |2 bisacsh 
650 7 |a Epstein-Barr virus  |2 fast 
650 7 |a Epstein-Barr virus diseases  |2 fast 
700 1 |a Münz, Christian,  |e editor. 
773 0 |t Springer eBooks 
776 0 8 |i Printed edition:  |z 9783319228334 
830 0 |a Current topics in microbiology and immunology ;  |v 391. 
856 4 0 |u https://ebookcentral.uam.elogim.com/lib/uam-ebooks/detail.action?docID=4178511  |z Texto completo 
938 |a Askews and Holts Library Services  |b ASKH  |n AH31356712 
938 |a Coutts Information Services  |b COUT  |n 32808104 
938 |a ProQuest Ebook Central  |b EBLB  |n EBL4178511 
938 |a EBSCOhost  |b EBSC  |n 1075983 
938 |a ProQuest MyiLibrary Digital eBook Collection  |b IDEB  |n cis32808104 
938 |a YBP Library Services  |b YANK  |n 12629948 
994 |a 92  |b IZTAP